For peritoneal dialysis (PD) patients, a falling serum albumin is rarely just a lab value, it’s an early signal of protein-energy wasting (PEW), and one of the strongest predictors of poor outcomes in ESRD. When albumin stays low despite good dietary adherence, the question isn’t whether to intervene, but how.
Intraperitoneal Nutrition (IPN) is often the most direct answer.
This guide covers when to consider IPN, the clinical criteria that support it, and how the referral process works.
Why Albumin Falls in Peritoneal Dialysis
PD patients face a nutritional challenge that’s built into the therapy itself: protein is lost continuously across the peritoneal membrane. On average, patients lose an estimated 5 to 15 grams of protein per day through their exchanges, and losses climb during peritonitis or with higher membrane transport rates.
Layered on top of that are the familiar drivers of malnutrition in ESRD: reduced appetite, chronic inflammation, metabolic acidosis, and restrictive renal diets. The result is that even a conscientious patient who follows every dietary recommendation can still see albumin drift downward. Oral intake alone often can’t offset a loss that’s happening at the level of the dialysis membrane.
Low Albumin as a Clinical Trigger
Serum albumin below
3.5 g/dL, persisting despite dietary counseling and oral supplements, is a widely used threshold for escalating nutritional support in dialysis patients. It shouldn’t be read in isolation, albumin is also affected by inflammation and volume status, but as part of a broader picture, it’s a meaningful trigger to reassess the nutrition plan.
Alongside albumin, clinicians typically look for:
- Unintentional weight loss (for example, >5% in 3 months or >10% in 6 months)
- Declining muscle mass or hand-grip strength
- Low prealbumin or transferrin
- Poor oral intake, early satiety, or GI intolerance to supplements
- Signs of a catabolic state (infection, wounds, chronic inflammation)
When several of these cluster together in a PD patient, IPN moves from "consider" to "clinically indicated."
The Stepwise Nutrition Approach
IPN is not a first-line therapy, and positioning it correctly matters. Clinical guidelines support a progressive approach to renal malnutrition:
Step 1 - Dietary counseling. A renal dietitian builds an individualized nutrition plan and addresses barriers to intake.
Step 2 - Oral nutritional supplements (ONS). Renal-specific oral supplements are added to increase protein and calorie intake.
Step 3 - IPN. When Steps 1 and 2 are insufficient or not tolerated, IPN delivers protein directly during the PD exchange the patient already performs.
Just as important: reversible contributors, underdialysis, acidosis, active inflammation, should be optimized in parallel. IPN complements a well-managed dialysis prescription; it doesn’t compensate for an incomplete one.
How IPN Helps
Because the deficit in PD is largely a dialysis-associated protein loss, the most efficient fix is to replace protein within the dialysis exchange. That’s exactly what
Intraperitoneal Nutrition (IPN) therapy does: a sterile, individualized amino acid solution is substituted for one or more standard exchanges, delivering nutrients across the peritoneal membrane with no additional needle, no IV line, and no change to the patient’s routine. It’s compatible with both CCPD cyclers and CAPD manual exchanges.
Each formulation is compounded to the patient’s weight, albumin, dialysis prescription, and nutritional status, and adjusted over time as labs evolve.
Is IPN the Right Fit?
IPN is specific to peritoneal dialysis. For a malnourished patient on hemodialysis, the equivalent therapy is IDPN, the two are frequently confused, so it’s worth understanding
how IPN and IDPN differ before referring. The deciding factor is almost always the dialysis modality, followed by confirmation that first-line measures have already been tried.
Clinical Criteria at a Glance
IPN should be considered for a peritoneal dialysis patient with ESRD who presents with:
- Serum albumin persistently below 3.5 g/dL
- Unintentional weight loss or muscle wasting
- Inadequate protein intake despite dietary counseling
- A failed or poorly tolerated trial of oral supplements
- No contraindication to an increased peritoneal protein load
For a plain-language breakdown of eligibility, see our overview of
who qualifies for IPN.
The Referral Process
Pharmko is built to make escalation simple for the care team:
1. Physician referral. The nephrologist submits a prescription with clinical justification, the current PD regimen (bag size, dextrose concentration, number of exchanges), and recent labs.
2. Insurance verification. Pharmko handles prior authorization and benefits verification, most cases resolve within a few business days.
3. Compounding and delivery. We compound the patient-specific IPN solution in our USP <797>-compliant cleanroom and deliver it to the patient’s home, coordinated with their dialysis schedule.
4. Ongoing monitoring. Our clinical team tracks albumin, prealbumin, and other markers, communicating adjustments back to the prescribing team.
The Bottom Line
A low, stubborn albumin in a PD patient is a signal worth acting on. When dietary counseling and oral supplements haven’t moved the number, IPN offers a direct, low-burden way to replace the protein dialysis removes, compounded to the individual patient and coordinated end to end.
Have a peritoneal dialysis patient with low albumin? Refer them to Pharmko and we’ll handle the rest.
Refer a Patient → ·
1 (877) 540-2003
This article is for clinical and educational information and does not replace individualized medical judgment.
